Form 4 Tracker
NewAmsterdam Pharma Co N.V.
NAMS

11 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 27, 2026Jan 29 9:40 PMLouise Frederika KooijChief Accounting Officer
Sale
39,816$32.62$1.3M24,353(D)

View →

Jan 26, 2026Jan 27 10:38 PMLouise Frederika KooijChief Accounting Officer
Sale
34,400$32.78$1.1M24,353(D)

View →

Jan 23, 2026Jan 27 10:38 PMLouise Frederika KooijChief Accounting Officer
Sale
38,172$33.75$1.3M24,353(D)

View →

Jan 21, 2026Jan 22 10:24 PMMayur Ian SomaiyaChief Financial Officer
Sale
39,784$33.59$1.3M58,382(D)

View →

Jan 20, 2026Jan 22 10:24 PMMayur Ian SomaiyaChief Financial Officer
Sale
60,216$31.96$1.9M58,382(D)

View →

Jan 20, 2026Jan 20 9:17 PMMayur Somaiya
Proposed Sale
200,000$31.65$6.3M

View →

Jan 7, 2026Jan 7 6:19 PMMichael Davidson
Proposed Sale
11,582$35.48$410.9K

View →

Jan 6, 2026Jan 6 9:29 PMDouglas F Kling
Proposed Sale
300,000$33.48$10.0M

View →

Jan 5, 2026Jan 5 8:18 PMLouise Kooij
Proposed Sale
2,647$33.25$88.0K

View →

Jan 5, 2026Jan 5 8:04 PMJohannes Kastelein
Proposed Sale
6,000$33.25$199.5K

View →

Jan 5, 2026Jan 5 8:03 PMMayur Ian Somaiya
Proposed Sale
5,118$33.25$170.2K

View →

Dec 23, 2025Dec 23 10:31 PMLouise Kooij
Proposed Sale
290,000$36.49$10.6M

View →

Dec 2, 2025Dec 3 2:25 AMBain Capital Life Sciences Fund II, L.P.
Proposed Sale
267,429$38.33$10.3M

View →

Dec 2, 2025Dec 3 2:23 AMBCLS II Investco, LP
Proposed Sale
4,500,000$38.33$172.5M

View →

Dec 2, 2025Dec 3 2:22 AMBCIP Life Sciences Associates, LP
Proposed Sale
32,571$38.33$1.2M

View →

Sep 9, 2025Sep 9 3:57 PMLouise Kooij
Proposed Sale
150,000$25.20$3.8M

View →

Sep 3, 2025Sep 3 12:21 PMKooij Louise Frederika
Proposed Sale
18,073$24.05$434.7K

View →

Aug 25, 2025Aug 27 8:57 PMKooij Louise Frederika
Proposed Sale
8,269$25.19$208.3K

View →

Aug 21, 2025Aug 25 9:03 PMKastelein Johannes Jacob Pieter
Proposed Sale
100,000$25.00$2.5M

View →

Jul 14, 2025Jul 14 8:12 PMNAP PoolCo B.V.
Proposed Sale
1,433,193$21.56$30.9M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 22, 2026Jun 24 8:10 PMLouise Frederika KooijChief Accounting Officer
Option Exercise
40,000$11.9035,000(D)

View →

May 26, 2026May 27 8:30 PMLouise Frederika KooijChief Accounting Officer
Option Exercise
65,000$10.9068,134(D)

View →

Mar 9, 2026Mar 11 12:58 AMLouis G LangeDirector
X
44,619$11.500(D)

View →

Mar 9, 2026Mar 10 12:18 AMJohannes Jacob Pieter KasteleinDirector, Chief Scientific Officer
Option Exercise
101,409520,229(I)

View →

Mar 6, 2026Mar 10 12:18 AMJohannes Jacob Pieter KasteleinDirector, Chief Scientific Officer
Option Exercise
94,124621,638(I)

View →

Mar 5, 2026Mar 10 12:18 AMJohannes Jacob Pieter KasteleinDirector, Chief Scientific Officer
Option Exercise
104,467715,762(I)

View →

Mar 2, 2026Mar 2 11:08 PMMichael H. DavidsonDirector, Chief Executive Officer
Option Exercise
443,707239,267(D)

View →

Feb 26, 2026Feb 27 2:40 AMMichael H. DavidsonDirector, Chief Executive Officer
Option Exercise
183,332682,974(D)

View →

Feb 25, 2026Feb 27 2:40 AMMichael H. DavidsonDirector, Chief Executive Officer
Option Exercise
58,253866,306(D)

View →

Feb 24, 2026Feb 27 2:40 AMMichael H. DavidsonDirector, Chief Executive Officer
Option Exercise
64,708924,559(D)

View →

Jan 28, 2026Jan 29 9:40 PMLouise Frederika KooijChief Accounting Officer
Option Exercise
32,612$10.9073,134(D)

View →

Jan 27, 2026Jan 29 9:40 PMLouise Frederika KooijChief Accounting Officer
Option Exercise
39,816$10.90105,746(D)

View →

Jan 26, 2026Jan 27 10:38 PMLouise Frederika KooijChief Accounting Officer
Option Exercise
34,400$10.90145,562(D)

View →

Jan 23, 2026Jan 27 10:38 PMLouise Frederika KooijChief Accounting Officer
Option Exercise
38,172$10.90179,962(D)

View →

Jan 21, 2026Jan 22 10:24 PMMayur Ian SomaiyaChief Financial Officer
Option Exercise
39,784$9.26662,814(D)

View →

Jan 20, 2026Jan 22 10:24 PMMayur Ian SomaiyaChief Financial Officer
Option Exercise
60,216$9.26702,598(D)

View →